{
    "2020-12-30": [
        [
            {
                "time": "2021-10-28",
                "original_text": "Regeneron (REGN) Releases Initial Data on Cocktail for COVID-19",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "REGN",
                        "Cocktail",
                        "COVID-19",
                        "Initial Data"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-10-28",
                "original_text": "Regeneron’s Antibodies Appear to Help Hospitalized Patients—and Could Help 2021 Revenue",
                "features": {
                    "keywords": [
                        "Regeneron’s Antibodies",
                        "Hospitalized Patients",
                        "2021 Revenue"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}